Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15305693 | 0.89 | CYP1A2 (0.80) | CYP1A2SMN1; SMN2MAPTTP53GLA | |
| SCHEMBL8431787 | 0.86 | CYP1A2 (0.75) | CYP1A2SMN1; SMN2MAPTTP53GLA | |
| SCHEMBL3791688 | 0.84 | CYP1A2 (0.72) | CYP1A2SMN1; SMN2MAPTTP53GLA | |
| SCHEMBL2702801 | 0.84 | CYP1A2 (0.72) | CYP1A2SMN1; SMN2MAPTTP53GLA | |
| SCHEMBL2775380 | 0.82 | CYP1A2 (0.70) | CYP1A2SMN1; SMN2MAPTTP53GLA | |
| SCHEMBL2703472 | 0.82 | CYP1A2 (0.70) | CYP1A2SMN1; SMN2MAPTTP53GLA | |
| SCHEMBL8303247 | 0.82 | CYP1A2 (0.70) | CYP1A2SMN1; SMN2MAPTTP53GLA | |
| SCHEMBL8324577 | 0.81 | CYP1A2 (0.68) | CYP1A2SMN1; SMN2MAPTTP53GLA | |
| SCHEMBL12719643 | 0.81 | CYP1A2 (0.68) | CYP1A2SMN1; SMN2MAPTTP53GLA | |
| SCHEMBL9696374 | 0.79 | CYP1A2 (0.66) | CYP1A2SMN1; SMN2MAPTTP53GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10779540-B2 | Benzamide compounds and their use as herbicides | BASF SE (DE) | 2020-09-22 | — | — | US | disclosed |
| EP-3390372-B1 | BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2020-06-03 | — | — | EP | disclosed |
| WO-2017102275-A1 | BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2017-06-22 | — | — | WO | disclosed |
| EP-0279366-B1 | PROCESS FOR THE PREPARATION OF PYRIMIDINES | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-08-12 | — | — | EP | disclosed |
| US-4960887-A | REACTING PROPANEDIIMIDATE WITH CARBONIC ACID IMINEDERIVATIVE | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | disclosed |
| EP-0279366-A2 | Process for the preparation of pyrimidines | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10779540-B2 | Benzamide compounds and their use as herbicides | DDT, DNPH1, BBOX1 | CYP1A2 46/4885SMN1; SMN2 3108/4885MAPT 3277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.